References

1. 1.
   WANG M N，HUANG X K，LUO H Y，et al.Comparison of effect of hirudo，Notoginseng Radix et Rhizoma，and theircombinations on renal fibrosis in rats with chronic renal failure［J］.Chin J Exp Tradit Med Form，2024，30（2）：110-117.
2. 2.
   HAMDY M M，ABDEL-RAHMAN M S，BADARY D M，et al.Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats［J］.Eur J Med Res，2022，27（1）：117.
3. 3.
   YAMASHITA N，KRAMANN R.Mechanisms of kidney fibrosis and routes towards therapy［J］.Trends Endocrinol Metab，2024，35（1）：31-48.
4. 4.
   LIU X Z，MO J Y，YANG X R，et al.Causal relationship between gut microbiota and chronic renal failure：A two-sample Mendelian randomization study［J］.Front Microbiol，2024，15：1356478.
5. 5.
   CHEN J N，XIE L P，HUANG Y M，et al.Research progress of traditional Chinese medicine in the treatment of chronic renal failure［J］.J Pract Chin Intern Med，2024，38（1）：81-83.
6. 6.
   WEI H Y，LI Z T，WEI M，et al.Professor WEI Xiaona's experience in the treatment of chronic renal failure based on the "turbidity theory"［J］.Guid J Tradit Chin Med Pharm，2022，28（10）：109-111，118.
7. 7.
   LIU X，WEI X N，WANG H Y，et al.Clinical observation of turbidity and detoxification prescription combined with colon dialysis therapy in the treatment of chronic renal failure［J］.Chin J Integr Tradit West Nephrol，2018，19（9）：809-810.
8. 8.
   LI Z T，WEI H Y，LIU F R，et al.Effect of Huazhuo Jiedu prescription on TGF-β₁，α-SMA，HGF proteins and mRNA expression in kidney tissue of rats with chronic renal failure［J］.J Anhui Univ Chin Med，2022，41（6）：71-75.
9. 9.
   WANG Y，PING Z，GAO H，et al.LYC inhibits the Akt signaling pathway to activate autophagy and ameliorate TGFB-induced renal fibrosis［J］.Autophagy，2024，20（5）：1114-1133.
10. 10.
    REN M H，YANG L X，LIANG Y L，et al.Active components in Chinese medicinal herbs regulate AMPK/mTOR pathway to mediate autophagy in diabetic kidney disease：A review［J］.Chin J Exp Tradit Med Form，2023，29（18）：277-282.
11. 11.
    GWINN D M，SHACKELFORD D B，EGAN D F，et al.AMPK phosphorylation of raptor mediates a metabolic checkpoint［J］.Mol cell，2008，30（2）：214-226.
12. 12.
    ATWOOD D J，POKHREL D，BROWN C N，et al.Increased mTOR and suppressed autophagic flux in the heart of a hypomorphic PKD1 mouse model of autosomal dominant polycystic kidney disease［J］.Cell Signal，2020，74：109730.
13. 13.
    PLATT R，ROSCOE M H，SMITH F W.Experimental renal failure［J］.Clin Sci，1952，11（3）：217-231.
14. 14.
    LI R，SHI C R，WEI C T，et al.Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/Akt［J］.Phytomedicine，2023，116：154873.
15. 15.
    XU S Y，BIAN R L，CHEN X，et al.Methodology of pharmacological experiment［M］.3rd ed.Beijing：People's Health Press，2002：1261-1266.
16. 16.
    HUANG R S，FU P，MA L.Kidney fibrosis：From mechanisms to therapeutic medicines［J］.Sig Transduct Target Ther，2023，8（1）：129.
17. 17.
    LI Z H，ZHANG Q Q，MA C X，et al.Dredging Fu-organs and descending the turbid for chronic renal failure［J］.World Chin Med，2023，18（6）：817-822，827.
18. 18.
    SARI D C R，BUDIHARJO S，AFIFAH H，et al.Centella asiatica extract attenuates kidney fibrosis through reducing mesenchymal transition and inflammation in ureteral ligation model in mice［J］.Front Pharmacol，2021，12：621894.
19. 19.
    ZHAO H，LIU T，YANG C E，et al.Poricoic acid A attenuates renal fibrosis by inhibiting endoplasmic reticulum stress-mediated apoptosis［J］.Braz J Med Biol Res，2024，doi：.
20. 20.
    LIU W，GU R Z，LOU Y J，et al.Emodin-induced autophagic cell death hinders epithelial-mesenchymal transition via regulation of BMP-7/TGF-β₁ in renal fibrosis［J］.J Pharmacol Sci，2021，146（4）：216-225.
21. 21.
    TAN R Z，ZHONG X，LI J C，et al.An optimized 5/6 nephrectomy mouse model based on unilateral kidney ligation and its application in renal fibrosis research［J］.Ren Fail，2019，41（1）：555-566.
22. 22.
    ZHANG D Y.Optimization of glomerular filtration rate measurement and equation estimation in non-dialysis patients with end-stage renal disease and establishment of a calculation model for 24-hour urinary potassium excretion in hyperkalemia［D］.Beijing：Peking Union Medical College，2023.
23. 23.
    LI L，FU H Y，LIU Y H.The fibrogenic niche in kidney fibrosis：Components and mechanisms［J］.Nat Rev Nephrol，2022，18（9）：545-557.
24. 24.
    SHEN B Y，WANG Y L，CHENG J Q，et al.Pterostilbene alleviated NAFLD via AMPK/mTOR signaling pathways and autophagy by promoting Nrf2［J］.Phytomedicine，2023，doi：.
25. 25.
    LI J S，WANG Y M，YAN Y S，et al.Role of autophagy in renal interstitial fibrosis and intervention of Chinese medicine：A review［J］.Chin J Exp Tradit Med Form，2022，28（19）：274-282.
26. 26.
    HWANG H J，KIM Y K.The role of LC3B in autophagy as an RNA-binding protein［J］.Autophagy，2023，19（3）：1028-1030.
27. 27.
    LAMARK T，SVENNING S，JOHANSEN T.Regulation of selective autophagy：The p62/SQSTM1 paradigm［J］.Essays Biochem，2017，61（6）：609-624.
28. 28.
    LIU H，WANG Q，SHI G，et al.Emodin ameliorates renal damage and podocyte injury in a rat model of diabetic nephropathy via regulating AMPK/mTOR-mediated autophagy signaling pathway［J］.Diabetes Metab Syndr Obes，2021，14：1253-1266.
29. 29.
    TREFTS E，SHAW R J.AMPK：Restoring metabolic homeostasis over space and time［J］.Mol Cell，2021，81（18）：3677-3690.
30. 30.
    YANAGI T，KIKUCHI H，TAKEUCHI K，et al.ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease［J］.Kidney Int，2024，106（5）：887-906.
31. 31.
    STEINBERG G R，HARDIE D G.New insights into activation and function of the AMPK［J］.Nat Rev Mol Cell Biol，2023，24（4）：255-272.
32. 32.
    SMILES W J，OVENS A J，KEMP B E，et al.New developments in AMPK and mTORC1 cross-talk［J］.Essays Biochem，2024，68（3）：321-336.